Shudan Medical's Founder and CEO Cong Fang Confirms Participation in 2023 Future Healthcare Technology Conference

The latest 2023 Nature Index rankings, released recently, show that China has surpassed the United States for the first time, underscoring the rapid advancement of China’s scientific research capabilities and foundational research strength. Perhaps now, and in the near future, we should venture further into the vast, mysterious “uncharted territories,” becoming explorers, questioners, and pioneers.

From November 30 to December 1, 2023, the 2023 Future Healthcare Technology Conference will be held in Hefei.The conference will systematically review the 30 most noteworthy frontier technologies in the life and health sector, inviting research scholars aligned with these technological trends to share insights on emerging developments. It aims to create a premier technology showcase featuring launches of cutting-edge innovations, displays of innovative tech products, and ecosystem collaboration among medical technology enterprises. Having been successfully held for three consecutive editions, this year’s conference is expected to attract over 100 influential figures in technology, 100 tech companies, and 800 professional attendees.

Shudan Technology Founder and CEO Fang Cong Confirmed to Attend the 2023 Future Medical Technology Conference, and will address"Safeguarding Global Brain Health with Intelligent Technology"》Share insights on the topic.

Dr. Fang Cong holds a PhD in Molecular and Medical Pharmacology from UCLA, as well as an MBA and an MS in Bioengineering from MIT. In July 2021, he founded Shudan Medical. Prior to this, he served for four years as COO and Vice President at Yitu Healthcare, where he established and led the global business development and marketing brand teams, and worked with the CEO to secure multiple rounds of financing totaling hundreds of millions of RMB. Before joining Yitu, he was responsible for Amgen’s global clinical operations strategy and the digitalization of manufacturing information systems. During his tenure, he spearheaded the clinical manufacturing digitalization project, achieving full digital integration of Amgen’s clinical production. He previously served as Executive Sales Director for North America at Shanghai GenePharma Co., Ltd., where he was responsible for expanding the North American market.
and sales management. Previously served as a Research Scientist in Bioengineering at Cynvenio Biosystems, Inc., responsible for the research and development of novel methods for early cancer diagnosis using single-cell analysis.

Main Forum – Medical Technology Barometer Conference

Time: Nov 30–Dec 1 (2 days) 09:00–17:00

As the main forum of the 2023 Future Medical Technology Conference, the 2023 Future Medical Technology Trends Summit will be divided into four segments: the Opening Ceremony, Digital Technology, Biotechnology, and Intelligent Manufacturing. The event will focus on 30 major frontier technology trends and invite government officials, academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, leading scholars in frontier technologies, corporate representatives, and renowned investors to participate.

Themed Forum — Smart Medical Device Innovation Forum

Time: November 30, 13:30-17:00

Following the release of the 2019 Catalogue for Guiding Industrial Structure Adjustment, the development and application of high-end medical devices, such as AI-assisted medical equipment, have once again been included in the “Encouraged” category of the 2023 catalogue. This signifies that the integrated innovation of digital technologies and medical devices has become a significant development trend in the healthcare industry. This forum specially invites research experts, entrepreneurs in the intelligent medical device sector, and investors to comprehensively interpret the progress of intelligent medical devices from the perspectives of policy, upstream and downstream segments of the industrial chain, and capital markets, and to jointly explore future trends and innovative pathways for intelligent medical devices.

Themed Forum: Frontier Technological Innovation in Gene Sequencing

Time: November 30, 13:30–17:00

Gene sequencing stands out as one of the most prominent innovative technologies in cutting-edge science and clinical applications, representing a highly lucrative sector. In a remarkably short period, gene sequencing has given rise to an extensive industrial chain, with upstream segments comprising sequencers and consumables, midstream segments focusing on sequencing and data services, and downstream segments encompassing research and clinical applications. This forum will primarily explore advancements in frontier gene sequencing technologies and innovations in their applications.

Thematic Forum — Generative AI Scenario Innovation Application Forum

Time: December 1, 09:00-12:00

With the explosive growth and increasing diversification of medical data, the application of artificial intelligence in healthcare has become increasingly prevalent. Over the past year, generative AI, as the most creative and imaginative branch of artificial intelligence technologies, has firmly captured the attention of healthcare professionals. This forum will invite research experts, leading AI companies, and top-tier investors to provide in-depth insights into the latest developments and applications of generative AI, as well as its future opportunities.

2023 FTC 5th Frontier Technologies Forum in Cardiac Surgery

Time: December 1, 09:00-17:00

Co-hosted by the Cardiac Surgery Technology and Engineering Committee of the China Medical Biotechnology Association and Peking Union Medical College Hospital, and co-organized by VCBeat, the “2023 FTC 5th Frontiers in Cardiac Surgery Technology Forum” aims to bring together experts, scholars, corporate representatives, and industry professionals from both domestic and international cardiac surgery fields to jointly discuss technological advancements and development trends in cardiac surgery, as well as industrial innovation and collaboration opportunities.

The 3rd Conference of the Innovation and Translation Branch of Neurosurgery, China Association for Geriatric Health Care

Time: December 1, 09:00-17:00

Centered on the ITMNS Association’s clinical resources, the forum will synergize with regulatory review agencies, innovative enterprises, financial capital, and other resources for innovation translation. Through activities such as white paper releases, awards for outstanding projects, and sharing of innovative practices, it aims to build a platform for in-depth exchange and win-win cooperation among experts, scholars, entrepreneurs, and other stakeholders in the field of neurosurgery, fostering dialogue on frontier trends and collaborative applications in domestic neurosurgical translational research and industrial innovation.

For more details on conference speakers, seeCountdown to the Conference | First Batch of Speakers Announced for the 2023 Future Healthcare Technology Conference。